- About Us
- Nano-Social Network
- Nano Consulting
- My Account
August 8th, 2007
Jeff Williams has no illusions about why he was appointed chief executive of Platypus Technologies. His mission, and the company's mission, is to start actively commercializing the combination "bio" and "nano" technology that has been under development inside its New Venture Center facility.
Platypus, which helps researchers study chemical reactions with the help of nano-structured surfaces, is closer to launching a key assay, and Williams has ample experience bringing products to market at career stops like Roche Diagnostics and Ambion Diagnostics, where he was responsible for the commercialization of several FDA-regulated products.
|Related News Press|
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Nanoparticle exposure can awaken dormant viruses in the lungs January 17th, 2017
Nanoscale view of energy storage January 16th, 2017
New active filaments mimic biology to transport nano-cargo: A new design for a fully biocompatible motility engine transports colloidal particles faster than diffusion with active filaments January 11th, 2017